BRAINSTORM CELL THERAPEUTICS INC. Property, Plant and Equipment
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Property, Plant and Equipment of $152.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-14
- 2026-06-30: Property, Plant and Equipment, Net $152.00K.
- 2026-03-31: Property, Plant and Equipment, Net $198.00K.
- 2025-12-31: Property, Plant and Equipment, Net $235.00K.
- 2025-09-30: Property, Plant and Equipment, Net $283.00K.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $152.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $198.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $235.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $283.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $331.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $382.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $434.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $499.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $558.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $622.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $686.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $752.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $799.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $866.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $933.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $1.00M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.07M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.12M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.19M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.22M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.05M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.09M 10-Q · filed 2021-04-26 |
| 2020-12-31 | $1.12M 10-K · filed 2022-03-28 |
| 2020-09-30 | $950.00K 10-Q · filed 2020-10-15 |
| 2020-06-30 | $918.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $918.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $960.00K 10-K · filed 2021-02-04 |
| 2019-09-30 | $664.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $599.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $611.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $651.00K 10-K · filed 2020-02-18 |
| 2018-09-30 | $564.00K 10-Q · filed 2018-10-29 |
| 2018-06-30 | $596.00K 10-Q · filed 2018-07-23 |
| 2018-03-31 | $412.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $392.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | $358.00K 10-Q · filed 2017-10-17 |
| 2017-06-30 | $295.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $281.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $297.00K 10-K · filed 2018-03-08 |
| 2016-09-30 | $312.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $318.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $281.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $271.00K 10-K · filed 2017-03-29 |
| 2015-09-30 | $268.00K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $282.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $290.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $313.00K 10-K · filed 2016-03-09 |
| 2014-09-30 | $272.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $302.00K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $327.00K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $258.00K 10-K · filed 2015-03-26 |
| 2013-09-30 | $267.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $263.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $234.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $247.00K 10-K · filed 2014-03-27 |
| 2012-09-30 | $273.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $298.00K 10-Q/A · filed 2012-08-29 |
| 2012-03-31 | $328.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $314.00K 10-K · filed 2013-03-14 |
| 2011-09-30 | $341.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $380.00K 10-Q/A · filed 2011-09-07 |
| 2010-12-31 | $419.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |